참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Hydrochloric Acid | HCID 313 | — |
| 반응물 | Verapamil Hydrochloride | HCID 62969 | — |
| 용매 | Diethyl Ether | HCID 3283 | — |
| 용매 | Deuterium Oxide | HCID 24602 | — |
| 생성물 | Verapamil | HCID 2520 | — |
반응 단계
Verapamil hydrochloride was added to a solution of 25% deuterated sulfuric acid in deuterated water (v/v) and deuterated methanol. The solution was stirred for 140 hours at 90° C. The pH was adjusted to 12.0 and the mixture extracted with ethyl acetate. The combined ethyl acetate extracts were washed with water, dried over magnesium sulfate and evaporated to yield a viscous oil. This oil was dissolved in ether and ethereal hydrochloride was added to precipitate the hydrochloride salt. The salt was collected by filtration and crystallized from ethyl acetate to obtain deuterated verapamil as a white solid.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US05846514 |
|---|
| 출처 데이터셋 | uspto-grants-1998_12 |
|---|
| ORD ID | ord-ccb7ca7648b54acba23ed3a73cb71f88 |
|---|
| 출처 메모 | uspto-grants-1998_12 |
|---|